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Abstract: Thyroid hemiagenesis (TH) is characterized by the congenital absence of one thyroid lobe. The aim of this
study was to evaluate the calcium-phosphate balance in TH. Twenty patients with TH and 20 controls with a bilobed
thyroid were studied. Serum concentrations of total calcium, parathormon and calcitonin were measured. Addition-
ally, the immunohistochemical expression of calcitonin, chromogranin A (chA), neuron-specific enolase (NSE) and
calcitonin gene-related peptide (CGRP) was evaluated in surgical specimens from patients with TH and controls.
There were no significant differences in biochemical parameters between TH and controls. Positive staining for
calcitonin was demonstrated in 3/8 thyroid sections from three patients with TH, but only in 2/33 sections from four
controls (p < 0.005). All sections from patients with TH positive for calcitonin also expressed chA, NSE and CGRP.
Two sections from controls positive for calcitonin presented an additionally positive reaction for chA, and one of them
also for NSE. None presented positive staining for CGRP. Of three TH sections, in one, hyperplasia of C cells of
medium grade, and in another hyperplasia of C cells of high grade, could be detected. In the controls,  hyperplasia of
C cells of low and medium grade was observed. TH was associated with slightly enhanced C cells hyperplasia com-
pared to controls, which might indicate compensatory proliferation. However, the calcium-phosphate balance does
not seem to be significantly affected. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 2, pp. 299–305)
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Introduction
Histologically, the thyroid gland is formed by follic-
ular and parafollicular cells. Although sharing lo-
calization, these cells differ considerably in terms of
their origin and physiological role. The former con-
stitute thyroid follicles, and are engaged in the pro-
cess of production and release of thyroxine and tri-
iodothyronine. Parafollicular cells are scattered in
small clusters at the periphery of the follicles, pre-
dominantly in the central part of thyroid lobes. Their
main function is the production of calcitonin, the
hormone involved in regulating the calcium-phos-
phate balance [1].
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Precursors of follicular cells originate from the
endodermal epithelium, lining the floor of the mouth
between the 1st and 2nd pharyngeal arch [2]. The thy-
roid primordium is formed on 20th–22nd day of em-
bryogenesis, and then begins its descent along the
anterior pharyngeal wall, gradually gaining its bilobed
structure [3, 4]. On the 48th–50th day of development,
the gland reaches its final prelaryngeal localization.
Meanwhile, parafollicular cells precursors migrate
from the neural crest bilaterally towards the 4th and
5th pharyngeal pouches and subsequently locate within
the ultimobranchial bodies. These are twin structures,
which develop independently of thyroid anlage, mi-
grate towards the midline and on about the 44th day
fuse with the descending thyroid primordium. Even-
tually, they constitute about 1–30% of thyroid mass
[5]. Following the fusion, parafollicular cells carried
by ultimobranchial bodies disperse between the thy-
roid follicles and, therefore, the final histological
structure of a thyroid gland is formed, while ultimo-
branchial bodies disappear.
Thyroid hemiagenesis (TH) is a rare congenital
anomaly in which one of the thyroid lobes fails to
develop [6]. The etiopathogenesis of this entity is still
unknown. It is thought that impaired development of
ultimobranchial bodies may underlie the disturbed
formation of a bilobed structure of the thyroid in cas-
es of TH. It is not yet known whether TH is an isolat-
ed abnormality or whether concomitant developmen-
tal anomalies of other structures derived from pha-
ryngeal apparatus may coexist. One recently described
experimental model of TH are TBX-1 gene knock-
-out mice, characterized by developmental failure in
II–VI pharyngeal arches and II–IV pharyngeal pouch-
es [7]. Therefore, the animals present with a unilater-
al thyroid, devoid of parafollicular cells and parathy-
roid glands, associated with a lack of ultimobranchial
bodies formation [7, 8]. The bioavailability of parafol-
licular cells in subjects with TH is unknown, although
it has been hypothesized that their survival or activity
might be deteriorated [9]. To the best of our know-
ledge, neither the function of parafollicular cells nor
that of parathyroid glands in humans with TH has yet
to be systematically evaluated.
The aim of this study was to assess the possible
association between TH and concomitant alterations
of other structures derived from pharyngeal appara-
tus, which might potentially affect the calcium-phos-
phate balance.
Material and methods
The studied group consisted of 20 patients with TH
(16 women, four men), aged 35.4 ± 17.4 (mean ± SD), with
median value of 32 years, while the control group comprised
20 subjects with a normally developed thyroid gland,
matched for age and gender. Patients with a history of treat-
ment with monoclonal antibodies, chronic renal failure,
pernicious anemia or pregnant women were excluded from
the study.
A fasting morning specimen of blood was obtained from
each patient and kept on ice. Specimens affected by visible
hemolysis or lipemia were avoided. Red cells were separat-
ed within 30 minutes of collection and serum was frozen
immediately.
Serum concentration of total calcium, parathormon and
calcitonin were measured in basal conditions. Estimation
of total calcium concentration was performed using com-
plexometric assay and Roche kits. Parathormon concentra-
tion was determined with electrochemiluminescent assay
(ECLIA), via Roche Elecsys 1010/2010 analyzer, while cal-
citonin concentration was assessed using radioimmunoas-
say (RIA) and Brahms kits.
The obtained results were subjected to statistical analy-
sis. Serum concentrations of total calcium, parathormon and
calcitonin in patients with TH were compared to those in
the control group of subjects with a fully developed thyroid
gland. The significance of differences of the parameters
measured in an interval scale was performed with Student’s
t-test for unpaired data. All calculations were done with
STATISTICA version 8.0. Differences were assumed to be
significant at the level of p < 0.05.
Additionally, an immunohistochemical study of cal-
citonin expression in eight surgical specimens, obtained
from three patients with TH subjected to thyreoidecto-
my was performed. The same was performed in 33 con-
trol sections from surgical specimens obtained from four
patients with a normally developed, bilobed, thyroid
gland. All subjects were operated upon owing to medical
indications (non-toxic nodular goiter). Patients with the
diagnosis of colloid nodular goiter, and with malignancy
excluded upon routine histopathological examination, were
included in the study.
The thyroid sections were fixed in a 10% formalin solu-
tion and subsequently embedded in paraffin, and cut into
5 μm thick sections. The immunohistochemical staining was
performed according to ABC (Avidin–Biotynylated peroxi-
dase Complex) method. On the first day, sections were de-
paraffinized in xylene and hydrated in a row of alcohol
solutions of decreasing concentrations (100%, 90%, 85%,
80%, 70%), and subsequently washed in running water for
ten minutes. The next step involved blocking endogenous
peroxidase activity by incubation with 1% solution of hy-
drogen peroxide for 30 minutes. After subsequent washing
in running and, then in distilled, water, each for ten min-
utes, sections were incubated in a normal goat serum dilut-
ed 1:20 for 30 minutes. The key step was incubation with
adequately diluted (1:5) polyclonal rabbit anti-human anti-
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bodies to calcitonin (Dako) for about 18 hours at a temper-
ature of 4°C. On the next day, the incubation was continued
for one hour at room temperature and the sections were
washed in a phosphate buffered saline (PBS) three times
for three minutes in a shaker. Then, the sections were
washed in a Dako REALTM solution (Envision) for 30 min-
utes and, subsequently, in PBS three times for three min-
utes and, then, incubated with 3,3’-diaminobenzidine for 5–
–7 minutes, washed for ten minutes in running, and then for
ten minutes in distilled, water. Consecutively, the sections
were counterstained with hematoxylin (for two minutes) and
then washed in running water for ten minutes. Next, the
preparations were subjected to dehydration in a number of
alcohol solutions of increasing concentrations (70%, 85%,
90%, 95%, 100%) and treated with xylene. The final step
was closing each preparation with the use of Canadian balm
and cover glass. Each time a negative control was performed,
where specific antibodies were replaced with PBS.
In the preparations presenting positive staining for cal-
citonin, additional assessment of chromogranin A (chA),
neuron-specific enolase (NSE) and calcitonin gene-related
peptide (CGRP) expression was performed, with the use of
polyclonal rabbit anti-human antibodies to calcitonin and
chA (DAKO), as well as monoclonal mouse anti-human
antibodies to NSE (DAKO) and CGRP (Santa Cruz).
The study was approved by the local Ethics Committee,
and all patients gave informed consent for participation in
the project.
Results
The serum calcitonin concentration in patients with
TH was slightly lower compared to control subjects,
while the concentrations of calcium and parathormon
were comparable. However, there were no statisti-
cally significant differences between serum concen-
trations of calcitonin, total calcium and parathormon
between the two groups (Table 1).
All three patients with TH referred for surgery pre-
sented agenesis of a left thyroid lobe. Positive stain-
ing for calcitonin was demonstrated in three out of
eight (37.5%) thyroid sections from three patients
with TH, but only in two out of 33 (6.06%) sections
from four control patients (p < 0.005). All prepara-
tions from patients with TH, which were positive for
calcitonin, presented also positive reactions for chA,
NSE and CGRP. Two preparations from control sub-
jects, positive for calcitonin, presented additionally
a positive reaction for chA, and one of them also for
NSE. None, however, presented positive staining for
CGRP. Of three preparations from patients with TH,
in one preparation hyperplasia of parafollicular cells
of medium grade, and in another preparation hyper-
plasia of parafollicular cells of high grade, could be
detected (Figures 1). In comparison, in control prep-
arations, hyperplasia of C cells of low and medium
grade could be observed (Figure 2).
Discussion
An extensive search of the literature has revealed
about 300 cases of TH described to date. Most of the
patients presented with concomitant thyroid pathol-
ogies [6], including simple goiter [10], non-toxic [11]
and toxic nodular goiter [12], autonomous nodule [13],
Graves’ disease [14], Hashimoto’s thyroiditis [15],
subacute thyroiditis [16], congenital hypothyroidism
[17], accessory lingual thyroid [18], thyroglossal duct
cyst [19], papillary cancer [11] as well as follicular
cancer [20]. Interestingly, among numerous cases of
HT associated with different thyroid pathologies,
there were no reports of medullary cancer [20, 21].
In a number of patients, HT was accompanied by ex-
trathyroidal abnormalities, including parathyroid ad-
enoma [22], autoimmune polyglandular syndrome
type III [23], Williams syndrome [24], pituitary ade-
noma [25], Down syndrome [26], Marfan syndrome
[27], right aortic arch [28] or dysmorphic face with
short stature [29]. However, it has never been inves-
tigated whether TH is associated with disturbances
of the calcium-phosphate balance.
Although parathyroid glands develop in close
proximity to the thyroid, it is unknown whether de-
velopment of these structures is directly connected
or occurs independently.  Parathyroids are structures
derived from 3rd and 4th pharyngeal pouches, while
thyroid follicular cells develop from endoderm be-
tween the 1st and 2nd pharyngeal arch [2, 4]. It has
been hypothesized that secondarily to disturbed de-
velopment of a thyroid lobe in TH, the formation of
Table 1. Comparison of serum concentrations of calcitonin, total calcium and parathormon in patients with thyroid
hemiagenesis and control group of subjects with normally developed bilobed thyroid gland
Thyroid hemiagenesis Control group p
Calcitonin [pg/ml] 6.84 ± 3.8 8.54 ± 6.3 0.408
Total calcium [mg/dl] 9.62 ± 0.8 9.89 ± 0.6 0.331
Parathormon [pg/ml] 40.99 ± 16.8 42.96 ± 14.4 0.978
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surrounding structures derived from the pharyngeal
apparatus is aberrant, which might influence calci-
um, parathormon or calcitonin levels in these sub-
jects. In some cases of HT, on the side of the agenetic
lobe, no parathyroids or thyroid artery have been
demonstrated [22, 28, 30].
On the other hand, the number and localization of
parathyroid glands can vary greatly even among subjects
with a normal thyroid. Thus even the lack of two parathy-
roid glands on the side ipsilateral to the agenetic lobe
might not be reflected in detectable disturbances in cal-
cium or PTH concentrations, due to compensatory func-
tioning of the remaining two. In a patient described by
Sakurai et al., HT was diagnosed during diagnosis of
symptoms suggesting hyperparathyroidism [22]. During
the surgery, pre-operative diagnosis of one thyroid lobe
agenesis, as well as a lack of parathyroid glands at the
unilateral side, was confirmed. No thyroid arteries were
seen, but a recurrent laryngeal nerve of typical localiza-
tion was localized. Similarly, a lack of thyroid arteries
was detected on the side of a lobe agenesis in the stud-
ies by Mariani et al. as well as by Konno and Kanaya
[28, 30]. This might be a confirmation of a theory of
developmental failure of one thyroid lobe due to dis-
turbed vascularization. For the same reason, parathy-
roid glands on the same side may not develop. On the
other hand, Woods et al. demonstrated the presence of
two parathyroid glands also on the side of thyroid lobe
agenesis during the surgery of a patient with TH [31].
In our three patients with TH who were operated
upon, on the side of a single thyroid lobe two normal
parathyroid glands were seen, with no evidence of
hyperplasia and presenting typical location on the
posterior wall in the poles of a thyroid lobe. Due to
pre-operatively confirmed agenesis of one thyroid
lobe and lack of medical indications for exploration
of a contralateral side, the surgeons did not investi-
gate the other side of the neck, hence we could not
confirm the presence or absence of parathyroid glands
on the contralateral side. However, none of the pa-
tients presented (either pre- or postoperatively) symp-
toms of disturbed parathyroid function.
Data on the presence of C cells nests in the thy-
mus or parathyroid glands, and a described case of
a medullary cancer developing in the lingual thyroid,
indicate that parafollicular cells migration is occasion-
ally subject to aberration [5]. The localization of
C cells in subjects with thyroid agenesis is not known.
In these patients, cystic structures in the thyroid bed
are often visualized on ultrasound examination, al-
though these residues have not been evaluated im-
munohistochemically for the presence of parafollic-
ular cells [32]. Thus, the proximity of parathyroid
Figure 2. Calcitonin expression in a thyroid specimen from
a patient with a normally developed bilobed thyroid
(objective magnification × 10)
Figure 1. Calcitonin expression in a thyroid specimen from a patient with thyroid hemiagenesis. A — objective magnifica-
tion × 4; B — objective magnification × 10
A B
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glands and the thyroid, as well as reports on experi-
mental animals in which HT was associated with dis-
turbed C cells development, prompted us to evaluate
the calcium-phosphate balance in subjects with TH [7].
DiGeorge syndrome and Williams syndrome are
genetic disorders that have been found to be often
accompanied by TH. The former is associated with
the deletion of 7q11.23, containing genes implicated
in the SHH signalling [33, 34], while in the latter
haploinsufficiency of TBX1 gene is responsible for
the major developmental defects [35]. In mice with
the knock-out of TBX1 or SHH gene, thyroid devel-
ops as a unilobate gland resembling TH in humans
[7, 36]. In TBX1 –/– mice with TH, the proper histo-
genic pattern and functional differentiation of follic-
ular cells were confirmed by the expression of thyro-
globulin, TTF1 and TTF2, while no positive reaction
for calcitonin in the immunohistochemical examina-
tion was demonstrated. This was because that thy-
roid is devoid of the presence of parafollicular cells,
presumably due to disturbance of ultimobranchial
bodies formation [7]. Moreover, in TBX1 –/– mutant
embryos, number of C cells precursors in the sur-
roundings of thyroid anlage was significantly reduced.
Therefore, it was suggested that the proper biloba-
tion of the thyroid gland requires the presence of cells
of neuroectodermal origin. In addition, it has been
demonstrated that follicular cells begin to express thy-
roid-specific antigens only at the moment of fusion
with ultimobranchial bodies (Zabel M et al., unpub-
lished data). This hypothesis was confirmed in a study
of chick embryos, in which neural crest ablation led
to thyroid agenesis or hemiagenesis [37]. On the oth-
er hand, Demeester-Mirkine et al. hypothesized that
proper development of parafollicular cells requires
the presence of factors secreted by follicular cells,
while cells which did not migrate adequately would
not present a proper function [38]. In a study of SHH
knock-out mice, the expression of calcitonin in the
unilateral thyroid was not evaluated [36]. However,
embryos deficient in SHH or TBX1 present similar
defects in the head and neck region. Moreover, it has
been demonstrated that TBX1 is positively regulated
by SHH and its expression is abrogated in SHH defi-
cient mice [39].
Apart from the work by McHenry et al., where
a group of seven patients with HT was studied accord-
ing to the calcium concentration, and no abnormali-
ties were found [20], in the studies performed to date,
larger groups of subjects with TH have not been eval-
uated according to the state of the calcium-phosphate
balance and expression of parafollicular cells in
a hemiagenetic thyroid preparation.
Therefore, our study aimed to demonstrate the
presence or absence of C cells in surgical prepara-
tions from patients with TH, and to compare it to
the result of biochemical assessment of serum cal-
citonin concentration. By immunohistochemical ex-
amination, the presence of C cells in thyroid prep-
arations from subjects with TH was demonstrated
in amounts suggesting even compensatory hyper-
plasia in comparison to thyroid sections obtained
from patients with a bilobed gland. We hypothe-
size that observed hyperplasia represents a com-
pensatory mechanism in response to the congeni-
tal absence of one of the thyroid lobes. Further
studies on larger groups of patients are required to
confirm these results.
The clinical assessment of the calcium-phosphate
balance in subjects with thyroid dysgenesis has only
occasionally been studied. Daripa et al. demonstrat-
ed that subjects with congenital hypothyroidism due
to thyroid dysgenesis present comparable basal con-
centrations of calcium, parathormon and calcitonin,
but the calcium-stimulated calcitonin response is
blunted [9]. This corresponds to the results of our
study, performed on the group of patients with TH,
where no significant differences in these parameters
were observed compared to normal subjects. This is
probably because of compensatory hyperplasia of
parafollicular cells in the single thyroid lobe. It is also
possible that in subjects with TH, extrathyroid pro-
duction might play the role of a compensatory mech-
anism in response to the decreased number of C cells
in a single thyroid lobe as described in some patients
following total thyreoidectomy [40]. However, one
limitation of the study is that provocative tests, with
assessment of calcitonin level followed by adminis-
tration of calcium or pentagastrin, were not per-
formed. On the other hand, Demeester-Mirkine et
al. evaluated the basal and calcium-stimulated calci-
tonin concentration in subjects with congenital hy-
pothyroidism and found that the basal concentration
of calcitonin, as well as the secretory reserve of
parafollicular cells, were decreased [38]. Similar find-
ings were obtained by Carey et al. who demonstrated
calcitonin deficiency, as well as altered calcitonin re-
sponse, to calcium or pentagastrin infusion in chil-
dren with non-goitrous cretinism [41].
To summarize, our study provides the first immu-
nohistochemical demonstration of the presence of
parafollicular cells in subjects with TH. The analysis
of surgical specimens from patients with TH reveals
slightly enhanced parafollicular cells hyperplasia com-
pared to control preparations, which might be a re-
sult of compensatory stimulation in the presence of
a single thyroid lobe. However, the calcium-phosphate
balance does not seem significantly affected in pa-
tients with TH compared to subjects with a normally
developed thyroid gland.
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